SNShahani Noor

Shahani Noor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shahani Noor has a total of 94 co-authors. Here are the top co-authors by number of shared publications:

  • Andrea A. Pasmay

    Department of Neurosciences, University of New Mexico HSC, Reginald Heber Fitz Hall-145, MSC08 4740, Albuquerque, NM, 87131, USA

    4 shared publications
  • Andrea A. Pasmay

    Department of Neurosciences University of New Mexico HSC Albuquerque New Mexico USA

    4 shared publications
  • Ariana N. Pritha

    Department of Neurosciences, University of New Mexico HSC, Reginald Heber Fitz Hall-145, MSC08 4740, Albuquerque, NM 87131, United States

    4 shared publications
  • Ariana N. Pritha

    Department of Neurosciences University of New Mexico HSC Albuquerque New Mexico USA

    4 shared publications
  • Melody S. Sun

    Department of Neurosciences, University of New Mexico HSC, Reginald Heber Fitz Hall-145, MSC08 4740, Albuquerque, NM 87131, United States

    4 shared publications
  • Nikolaos Mellios

    Department of Neurosciences University of New Mexico HSC Albuquerque New Mexico USA

    4 shared publications

Latest Publications

  • Open Access

    Prenatal Alcohol Exposure Produces Selective Changes in Neuroimmune Gene Expression Across Brain Regions of Adult Mice

    by Alissa N. Jones, Ariana N. Pritha, Ashlynn M. Aguilar, Andrea A. Pasmay, Justin R. Carter, Nikolaos Mellios, Shahani Noor

    Background: An overwhelming body of evidence suggests neuroimmune dysfunction as a key underlying mechanism of fetal alcohol spectrum disorder (FASD)‐associated adverse central nervous system (CNS) outcomes. While few studies have highlighted the lingering effects of prenatal alcohol exposure (PAE) on producing specific immune factors, others suggest a primed neuroimmune state in adulthood, in which a proinflammatory bias is unmasked following subsequent immune activation in later life. However, the PAE‐induced neuroimmune landscape in adulthood remains poorly defined. We hypothesized that PAE induces long‐term changes in gene expression linked to neuroimmune function that may be brain region‐specific. Methods: Using long‐read next‐generation RNA sequencing of brain tissues from a previously established model of a moderate PAE in mice, we compared across six regions: medial prefrontal cortex (mPFC), anterior cingulate cortex (ACC), hypothalamus, hippocampus, midbrain, and medulla. A comprehensive bioinformatics analysis investigated PAE‐induced changes, dysregulated gene pathways, and transcriptional regulators with a focus on neuroimmune function. Results: Our data identified at least 60 differentially expressed genes per brain region, many of which were associated with neuroimmune function. Upregulation of multiple pro‐inflammatory factors and pathways was observed, suggesting ongoing baseline neuroimmune activation, potentially involving PXR, TNF, TLR4, the complement pathway, and various cytokine and chemokine signaling. A comparative analysis identified multiple upstream transcriptional regulators across multiple brain regions, including MECP2, TCF7L2, and IL‐4. Importantly, this unbiased analysis revealed heterogeneity across brain regions in the activation of canonical immune pathways and highlighted previously unprecedented roles of pathways such as PXR, matrix metalloproteases, and cytokine signaling (e.g., IL‐15, IL‐27, IL‐17) in PAE. Conclusions: PAE creates a unique inflammatory signature in the adult brain, even in the absence of secondary injury, with novel patterns of region‐specific changes in genes implicated in glial‐immune function. These data identify potential immune targets to elucidate the mechanisms underlying behavioral dysfunction and provide a framework for future therapeutic interventions.


  • Open Access

    Unraveling a comparative landscape of protein-coding genes linked to neuroimmune function during adulthood consequent of prenatal alcohol exposure

    by Alissa Jones, Ariana N Pritha, Ashlynn M Aguilar, Andrea A Pasmay, Justin R Carter, Nikolaos Mellios, Shahani Noor

    Background: An overwhelming body of evidence suggests neuroimmune dysfunction as a key underlying mechanism of FASD-associated adverse CNS outcomes. While few studies have highlighted the lingering effects of prenatal alcohol exposure (PAE) on producing specific immune factors, others suggest a primed neuroimmune state in adulthood, in which a proinflammatory bias is unmasked following subsequent immune activation in later-life. However, the PAE-induced neuroimmune landscape in adulthood remains poorly defined. We hypothesized that PAE induces long-term changes in gene expression linked to neuroimmune function that may be brain region-specific. Methods: Using long-read next-generation RNA sequencing of brain tissues from a previously established model of a moderate PAE in mice, we compared across six regions: medial prefrontal cortex (mPFC), anterior cingulate cortex (ACC), hypothalamus, hippocampus, midbrain, and medulla. A comprehensive bioinformatics analysis investigated PAE-induced changes, dysregulated gene pathways, and transcriptional regulators with a focus on neuroimmune function. Results: Our data identified at least 60 differentially expressed genes per brain region, many of which were associated with neuroimmune function. Upregulation of multiple proinflammatory factors and pathways was observed, suggesting ongoing baseline neuroimmune activation, potentially involving PXR, TNF, TLR4, the complement pathway, and various cytokine and chemokine signaling. A comparative analysis identified multiple upstream transcriptional regulators across multiple brain regions, including MECP2, TCF7L2, and IL-4. Importantly, this unbiased analysis revealed heterogeneity across brain regions in the activation of canonical immune pathways and highlighted previously unprecedented roles of pathways such as PXR, matrix metalloproteases, and cytokine signaling (e.g., IL-15, IL-27, IL-17) in PAE. Conclusions: PAE creates a unique inflammatory signature in the adult brain, even in the absence of secondary injury, with novel patterns of region-specific changes in genes implicated in glial-immune function. These data identified potential immune targets to elucidate the mechanisms underlying behavioral dysfunction and provide a framework for future therapeutic interventions.

  • Open Access

    Prenatal alcohol exposure promotes nerve injury-induced pathological pain following morphine treatment via NLRP3-mediated peripheral and central proinflammatory immune actions

    by Andrea A. Pasmay, Ariana N. Pritha, Justin R. Carter, Alissa Jones, Annette K. Fernandez-Oropeza, Melody S. Sun, Diane C. Jimenez, Minerva Murphy, C.FErnando Valenzuela, Shahani Noor


  • Open Access

    Prenatal alcohol exposure promotes nerve injury-induced pathological pain following morphine treatment via NLRP3-mediated peripheral and central proinflammatory immune actions

    by Andrea A. Pasmay, Ariana N. Pritha, Justin R Carter, Alissa Jones, Annette K. Fernandez-Oropeza, Melody S. Sun, Diane C. Jimenez, Minerva Murphy, C. Fernando Valenzuela, Shahani Noor

    Adverse in-utero conditions may exert a lifelong impact on neuroimmune function. Our prior work showed that prenatal alcohol exposure (PAE) increases pathological pain sensitivity (allodynia) following peripheral sciatic nerve injury. While the immune mechanism(s) of PAE-induced immune dysfunction are poorly understood, prior studies implicated the involvement of Toll-like receptor 4 (TLR4) and the nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-containing 3 (NLRP3) inflammasomes. Interestingly, emerging data suggest a surprising overlap of spinal glial proinflammatory activation via the TLR4-NLRP3-interleukin (IL)-1β axis due to opioid treatment in nerve-injured non-PAE rodents. Considering this preclinical evidence, we explored whether PAE poses a risk factor in creating proinflammatory immune bias consequent to opioid (morphine) exposure. We hypothesized that under nerve injury conditions, PAE may interact with morphine, promoting peripheral and CNS proinflammatory factors in a NLRP3-dependent manner. Using a minor nerve injury model in adult mice, we demonstrate that PAE prolongs the chronicity of ongoing allodynia in both sexes, with a more pronounced effect observed in male mice. Our study shows that PAE amplifies proinflammatory responses at the injury site and the spinal cord, driving morphine-prolonged allodynia through NLRP3 inflammasome activation. Furthermore, high mobility group box 1 (HMGB1), a well-established pain-promoting TLR4 agonist, is elevated in allodynic PAE mice. NLRP3 inhibitor, MCC950, effectively reverses morphine-induced allodynia and reduces Caspase-1 activity, IL-1β, and related proinflammatory factors. Although few sex-specific effects were observed, our data convincingly support that PAE and morphine interactions ultimately converge on NLRP3-driven mechanisms in both sexes. Together, this study suggests that PAE modulates later-life neuroimmune function and provides critical insights into immune regulators underlying PAE-induced biological vulnerability to pathological pain processing and adverse effects of opioids.


  • Recent Advances in the Role of Non-coding RNAs in Fetal Alcohol Spectrum Disorders

    by Ariana N. Pritha, Andrea A. Pasmay, Shahani Noor

    Despite numerous preclinical studies modeling fetal alcohol spectrum disorder (FASD)-associated neurodevelopmental deficits to date, a comprehensive molecular landscape dictating these deficits remains poorly understood. Non-coding RNAs constitute a substantial layer of epigenetic regulation of gene expression at the transcriptional, post-transcriptional, translational, and post-translational levels. Yet, little is known about the differential expression of non-coding RNAs in the context of prenatal alcohol exposure (PAE) that are mechanistically linked with FASD-related neurobehavior deficits. This chapter reviews our current knowledge from preclinical studies in non-coding RNA-mediated molecular mechanisms that may underlie FASD pathophysiology. This chapter also summarizes relevant clinical evidence and current efforts in utilizing these non-coding RNA molecules as biomarkers of PAE-associated deficits impacting central nervous system (CNS) function. Unraveling the diverse roles of various species of non-coding RNAs is critical to enhancing our comprehension of these intricate molecular pathways. Understanding these pathways would likely contribute to identifying critical molecular target(s) for developing efficient treatment strategies and prognostic and diagnostic markers fostering advancements in treating and managing FASD-related CNS dysfunction.


  • Open Access

    Neuroimmune mechanisms of a mouse model of chronic back pain

    by Aleyah E. Goins, Nesia A. Zurek, Cristian O. Holguin, Alexis Gravelle, Sachin Goyal, Shahani Noor, Jenna B. Demeter, Maddy R. Koch, June Bryan I. de la Peña, Karin N. Westlund, et al.

    Chronic back pain (CBP) is the leading cause of disability affecting 1 in 10 people worldwide. Symptoms are marked by persistent lower back pain, reduced mobility, and heightened cold sensitivity. Here, we utilize a mouse model of CBP induced by injecting urokinase-type plasminogen activator (uPA), a proinflammatory agent in the fibrinolytic pathway, between the L2/L3 lumbar vertebrae. We identified neuroimmune interactions contributing to uPA-induced CBP (henceforth, uPA-CBP) in mouse dorsal root ganglia (DRG), where nociceptive neurons reside. Flow cytometric data reveal that uPA-CBP increases CD45+CD11b+ cells in the DRG, a population characteristically implicated in other chronic pain models 1 . Blocking colony stimulating factor 1 receptor (CSF1R) signaling using PLX5622 partially reduced pain, suggesting CD45+CD11b+ macrophage involvement. Whole-cell patch-clamp electrophysiology data indicated DRG neuron hyperexcitability in CBP mice compared to controls. RNA sequencing revealed upregulation of pain- and inflammation-related genes involved in leukocyte migration. Together, these findings underscore the importance of the DRG neuroimmune axis in mediating chronic back pain. Highlights: uPA-CBP induces gait changes, mechanical and thermal sensitivity compared to shams uPA-CBP mice show increased CD45+CD11b+ cells in DRG compared to shams uPA-CBP mice show neuronal excitability in DRG neurons compared to shams Pain behaviors are alleviated by pharmacologically blocking CSF1R signaling Dysregulation of inflammation- and ion channel-related genes in uPA-CBP DRG

  • Open Access

    Moderate Prenatal Alcohol Exposure Increases Toll-like Receptor Activity in Umbilical Cord Blood at Birth: A Pilot Study

    by Jessie R. Maxwell, Shahani Noor, Nathaniel Pavlik, Dominique E. Rodriguez, Lidia Enriquez Marquez, Jared DiDomenico, Sarah J. Blossom, Ludmila N. Bakhireva

    The prevalence of prenatal alcohol exposure (PAE) is increasing, with evidence suggesting that PAE is linked to an increased risk of infections. PAE is hypothesized to affect the innate immune system, which identifies pathogens through pattern recognition receptors, of which toll-like receptors (TLRs) are key components. We hypothesized that light-to-moderate PAE would impair immune responses, as measured by a heightened response in cytokine levels following TLR stimulation. Umbilical cord samples (10 controls and 8 PAE) from a subset of the Ethanol, Neurodevelopment, Infant and Child Health Study-2 cohort were included. Peripheral blood mononuclear cells (PMBCs) were stimulated with one agonist (TLR2, TLR3, TLR4, or TLR9). TLR2 agonist stimulation significantly increased pro-inflammatory interleukin-1-beta in the PAE group after 24 h. Pro- and anti-inflammatory cytokines were increased following stimulation with the TLR2 agonists. Stimulation with TLR3 or TLR9 agonists displayed minimal impact overall, but there were significant increases in the percent change of the control compared to PAE after 24 h. The results of this pilot investigation support further work into the impact on TLR2 and TLR4 response following PAE to delineate if alterations in levels of pro- and anti-inflammatory cytokines have clinical significance that could be used in patient management and/or attention to follow-up.


  • Open Access

    Maternal Alcohol Drinking Patterns Predict Offspring Neurobehavioral Outcomes

    by Abbey Myrick, Diane Jimenez, Belkis Jacquez, Melody S. Sun, Shahani Noor, Erin D. Milligan, C. Fernando Valenzuela, David N. Linsenbardt

    SIGNIFICANCE The timing, rate, and quantity of gestational alcohol consumption, collectively referred to here as Maternal Drinking Patterns (MDPs), are of known importance to fetal developmental outcomes. Though studies in rodents exist that have investigated the impact of gestational alcohol drinking characteristics, few have sought to determine the impact of MDPs on offspring behavioral outcomes. METHODS We first used specialized equipment to record the precise amount and timing of binge alcohol consumption in pregnant mouse dams, and then characterized MDPs using Principle Component Analysis (PCA). We focused these analyses on the first fifteen minutes of every gestational drinking session when dams consumed the majority of each session’s alcohol (a phenomenon known as front-loading), as well as the entire 2 hour session across all days of gestation. We next tested offspring in open field and rotarod assays and evaluated these behavioral results in the context of MDPs. RESULTS Male alcohol exposed mice exhibited longer latencies to fall on the rotarod compared to their controls, which we attribute to a delayed decrease in body weight-gain not observed in females. This effect was found to be associated with MDPs within the first fifteen minutes of drinking, but not other MDPs. Female alcohol exposed mice had significantly reduced total locomotor activity in the open field compared to controls, and this effect was also associated with MDPs but only of the entire drinking session. Surprisingly, total gestational alcohol consumption alone was not associated with any particular behavioral outcome. Furthermore, we replicated robust behavioral data demonstrating development of allodynia in alcohol exposed mice where it did not develop in controls. CONCLUSIONS To our knowledge, this report represents the highest resolution assessment of alcohol drinking throughout gestation, and one of few to have identified relationships between specific alcohol MDPs and neurobehavioral outcomes in offspring. Specifically, based on characteristics of the PCA groups, we found evidence that the rate of alcohol front-loading leads to developmental delays in males, whereas an interaction of front-loading rate and duration, overall persistence, and total amount consumed lead to a female-only decrease in locomotor activity. Beyond these results, we provide a method for precise and accessible tracking of such data.

  • Prenatal alcohol exposure promotes NLRP3 inflammasome‐dependent immune actions following morphine treatment and paradoxically prolongs nerve injury‐induced pathological pain in female mice

    by Shahani Noor, Melody S. Sun, Andrea A. Pasmay, Ariana N. Pritha, Chaselyn D. Ruffaner‐Hanson, Monique V. Nysus, Diane C. Jimenez, Minerva Murphy, Daniel D. Savage, C. Fernando Valenzuela, et al.

    Background: Neuroimmune dysregulation from prenatal alcohol exposure (PAE) may contribute to neurological deficits associated with fetal alcohol spectrum disorders (FASD). PAE is a risk factor for developing peripheral immune and spinal glial sensitization and release of the proinflammatory cytokine IL‐1β, which lead to neuropathic pain (allodynia) from minor nerve injury. Although morphine acts on μ‐opioid receptors, it also activates immune receptors, TLR4, and the NLRP3 inflammasome that induces IL‐1β. We hypothesized that PAE induces NLRP3 sensitization by morphine following nerve injury in adult mice.Methods: We used an established moderate PAE paradigm, in which adult PAE and non‐PAE control female mice were exposed to a minor sciatic nerve injury, and subsequent allodynia was measured using the von Frey fiber test. In control mice with standard sciatic damage or PAE mice with minor sciatic damage, the effects of the NLRP3 inhibitor, MCC950, were examined during chronic allodynia. Additionally, minor nerve‐injured mice were treated with morphine, with or without MCC950. In vitro studies examined the TLR4‐NLRP3‐dependent proinflammatory response of peripheral macrophages to morphine and/or lipopolysaccharide, with or without MCC950.Results: Mice with standard sciatic damage or PAE mice with minor sciatic damage developed robust allodynia. Blocking NLRP3 activation fully reversed allodynia in both control and PAE mice. Morphine paradoxically prolonged allodynia in PAE mice, while control mice with minor nerve injury remained stably non‐allodynic. Allodynia resolved sooner in nerve‐injured PAE mice without morphine treatment than in morphine‐treated mice. MCC950 treatment significantly shortened allodynia in morphine‐treated PAE mice. Morphine potentiated IL‐1β release from TLR4‐activated PAE immune cells, while MCC950 treatment greatly reduced it.Conclusions: In female mice, PAE prolongs allodynia following morphine treatment through NLRP3 activation. TLR4‐activated PAE immune cells showed enhanced IL‐1β release with morphine via NLRP3 actions. Similar studies are needed to examine the adverse impact of morphine in males with PAE. These results are predictive of adverse responses to opioid pain therapeutics in individuals with FASD.